Todd Zavodnick's guest appearances

Todd Zavodnick

podcast – Don Burdge

Biotech 2050 Podcast

My Company Story

Peter Diamandis

Cynthia Johnson

Logan Gelbrich

Robert Gould

Phoebe Yu

Jesse Howard

Jim Burns

Rob Jorgensen

David Berry

David Bates

Jim Sullivan

Tim Sweeney

Tim Miller

Sean Whalen

Mike White

OwlTail

Atopic Dermatitis

Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry. Prior to joining Dermavant in November 2018, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He served in global leadership roles at ZELTIQ Aesthetics prior to the company’s acquisition by Allergan; at Galderma Laboratories, where he was President and General Manager of North America; and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation.On August 10, 2021, after this interview was recorded, Dermavant Sciences announced that the FDA accepted for filing a New Drug Application (NDA) for tapinarof for the treatment of plaque psoriasis in adult patients. Tapinarof is an investigational, novel, therapeutic aryl hydrocarbon receptor modulating agent, in development as a once-daily, steroid-free and cosmetically elegant topical cream for the treatment of plaque psoriasis and atopic dermatitis. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date in Q2 2022.

Todd Zavodnick has over 20 years of leadership experience in the biopharmaceutical industry. Prior to joining Dermavant in November 2018, Mr. Zavodnick served as Chief Commercial Officer and President of Aesthetics and Therapeutics at Revance. He served in global leadership roles at ZELTIQ Aesthetics prior to the company’s acquisition by Allergan; at Galderma Laboratories, where he was President and General Manager of North America; and at Alcon Laboratories. He is a member of the board of directors of the Children’s Skin Disease Foundation. On August 10, 2021, after this interview was recorded, Dermavant Sciences announced that the FDA accepted for filing a New Drug Application (NDA) for tapinarof for the treatment of plaque psoriasis in adult patients. Tapinarof is an investigational, novel, therapeutic aryl hydrocarbon receptor modulating agent, in development as a once-daily, steroid-free and cosmetically elegant topical cream for the treatment of plaque psoriasis and atopic dermatitis. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date in Q2 2022.

70. Modern treatments for psoriasis and atopic dermatitis, Todd Zavodnick, CEO, Dermavant Sciences

In this episode, Don interviews Todd Zavodnick! Todd is the CEO of Dermavant, a clinical-stage biopharmaceutical company. Dermavant develops and commercializes innovative therapies for a variety of medical dermatologic conditions, bringing a novel approach to the science of medicine. Todd goes in-depth about maintaining a steady operational rhythm in your business. He explains that in order to uphold your operational rhythm, clarity is everything. It comes down to having clear channels of communication, proper procedures, and the alignment of goals and values. Todd’s top 3 values for entrepreneurs are: constant curiosity, self-awareness, and adaptability/agility. Learn More About Todd Zavodnick  Twitter LinkedIn Website  Stay Connected with Don Burdge  Website LinkedIn Twitter  About My Company Story A Podcast for business owners by business owners. Each Episode will explore the challenges business owners face and how they’ve overcome them.

In this episode, Don interviews Todd Zavodnick! Todd is the CEO of Dermavant, a clinical-stage biopharmaceutical company. Dermavant develops and commercializes innovative therapies for a variety of medical dermatologic conditions, bringing a novel approach to the science of medicine. Todd goes in-depth about maintaining a steady operational rhythm in your business. He explains that in order to uphold your operational rhythm, clarity is everything. It comes down to having clear channels of communication, proper procedures, and the alignment of goals and values. Todd’s top 3 values for entrepreneurs are: constant curiosity, self-awareness, and adaptability/agility. Learn More About Todd Zavodnick <ul> <li><a href="https://twitter.com/zavodnick?lang=en" rel="nofollow" target="_blank">Twitter</a></li> <li><a href="https://www.linkedin.com/in/todd-zavodnick-8625911/" rel="nofollow" target="_blank">LinkedIn</a></li> <li><a href="https://dermavant.com/" rel="nofollow" target="_blank">Website</a></li> </ul> Stay Connected with Don Burdge <ul> <li><a href="https://mycompanystory.com/" rel="nofollow" target="_blank">Website</a></li> <li><a href="https://www.linkedin.com/in/donburdge/" rel="nofollow" target="_blank">LinkedIn</a></li> <li><a href="https://twitter.com/My_CompanyStory" rel="nofollow" target="_blank">Twitter</a></li> </ul> About My Company Story A Podcast for business owners by business owners. Each Episode will explore the challenges business owners face and how they’ve overcome them.

Todd Zavodnick, CEO of Dermavant